• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Health Technology Assessment programme Randomised controlled trial of Tumour necrosis factor inhibitors Against Combination Intensive Therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews
2014     Blue Cross Blue Shield Association (BCBS) CYP2D6 pharmacogenomics of tamoxifen treatment
2014     Penn Medicine Center for Evidence-based Practice (CEP) Psychosocial interventions for patients with sickle cell disease
2014     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for recurrent or persistent stage IVB cervical cancer – in combination with chemotherapy
2014     Agency for Healthcare Research and Quality (AHRQ) Screening for gonorrhea and chlamydia: systematic review to update the U.S. Preventive Services Task Force Recommendations
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bone marrow aspiration or biopsy for patients with immune thrombocytopenia: clinical evidence
2014     Blue Cross Blue Shield Association (BCBS) Endovascular treatments for acute ischemic stroke in adults
2014     Haute Autorite de sante (HAS) [Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of an HPV test in primary screening for cervical cancer - Rapid report]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Observation care and the two midnight rule: current perspectives and publications (2013-2014)
2014     NIHR Horizon Scanning Centre (NIHR HSC) Cologuard® for colorectal cancer screening
2014     Agency for Healthcare Research and Quality (AHRQ) Medication therapy management interventions in outpatient settings
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Patient-controlled analgesia for acute injury transfers: a review of the clinical effectiveness, safety, and guidelines
2014     Blue Cross Blue Shield Association (BCBS) Cost-effectiveness studies of new hepatitis C treatments
2014     Haute Autorite de sante (HAS) [Assessment of the risks associated with aesthetic mesotherapy practices]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Second Addendum to Commission A13-44 (ipilimumab, new therapeutic indication)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Docusate for treatment of constipation
2014     NIHR Horizon Scanning Centre (NIHR HSC) Terahertz intraoperative breast cancer probe
2014     Agency for Healthcare Research and Quality (AHRQ) Imaging techniques for the diagnosis and staging of hepatocellular carcinoma
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ondansetron for post-operative nausea and vomiting in elderly patients: clinical effectiveness and safety
2014     Haute Autorite de sante (HAS) [Elements to evaluate for managing a patient in outpatient surgery]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of new and relevant recommendations, for the DMP "breast cancer"]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Intravenous insulin infusion: the evidence for safe nursing administration practice
2014     NIHR Horizon Scanning Centre (NIHR HSC) Betrixaban for the prevention of venous thromboembolism – first line
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) as maintenance therapy after first progression on bevacizumab for patients with advanced colorectal cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hand sanitizers for the prevention of infection transmission: comparative clinical effectiveness and clinical evidence
2014     University of York Value based commissioning of MSK Procedures: an appraisal of the evidence for the proposed policies
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Canagliflozin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Aspirin for VTE prophylaxis in hip and knee replacement surgery
2014     NIHR Horizon Scanning Centre (NIHR HSC) Cydar imaging overlay system for endovascular surgery
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiopulmonary resuscitation for elderly adults in chronic or long-term care: clinical effectiveness and guidelines
2014     University of York Effects of lay-led self-care education programmes
2014     Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-05 (sofosbuvir)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Association of lumen number and diameter with complications in peripherally-inserted central catheters
2014     NIHR Horizon Scanning Centre (NIHR HSC) OPTIMIZER™ system for chronic heart failure
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ibrutinib (Imbruvica®) for relapsed or refractory CLL
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cataract surgery performed under local anaesthesia: guidelines
2014     Haute Autorite de sante (HAS) [Assessment of spinal cord stimulation]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pilot study: conjoint analysis in the indication "hepatitis C"]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Social media, text messaging, and post-discharge communication
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nellix® EndoVascular Aneurysm Sealing System for abdominal aortic aneurysm repair
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) for platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Medical marijuana for the treatment of mental illness: clinical evidence
2014     University of York Interventions to reduce unplanned admissions from care home settings
2014     Haute Autorite de sante (HAS) [Ultrasound guidance for peripheral nerve blockade]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Riociguat - Assessment according to § 35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Glucose monitoring and insulin administration for patients receiving total enteral nutrition
2014     NIHR Horizon Scanning Centre (NIHR HSC) ClearPath DS-120® for the detection and monitoring of diabetes
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme: from assessment to expert appraisal
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Immersion in water during active labour and delivery: clinical effectiveness, safety, and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cholic acid - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection
2014     NIHR Horizon Scanning Centre (NIHR HSC) Oxford Medical Diagnostics Breath Ketone Device for monitoring type 1 diabetes
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Procedural guidance for the systematic evaluation of biomarker tests
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short- and long-term use of benzodiazepines in patients with generalized anxiety disorder: a review of guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014     NIHR Health Technology Assessment programme PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study
2014     Penn Medicine Center for Evidence-based Practice (CEP) Improving processes of care and reducing readmissions for patients with sickle cell disease
2014     NIHR Horizon Scanning Centre (NIHR HSC) Obalon balloon for obesity
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Cost and budget impact analysis of an increase in day surgery for selected indications]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Simethicone administration during endoscopic procedures: clinical evidence and guidelines
2014     University of York Housing improvement and home safety
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Centralisation of bariatric surgery: policy implications
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dimethyl fumarate - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Gum chewing to reduce postoperative ileus among patients undergoing gastrointestinal surgery or cystectomy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pediatric Vision Scanner for the detection of eye conditions in children
2014     NIHR Health Services and Delivery Research programme Commissioning for long-term conditions: hearing the voice of and engaging users – a qualitative multiple case study
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Saxagliptin + metformin (Komboglyze — AstraZeneca) indication: type 2 diabetes mellitus
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Spinal surgery for chronic low back pain: review of clinical evidence and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-12 (canagliflozin)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Carto Univu for cardiac ablation
2014     NIHR Horizon Scanning Centre (NIHR HSC) OkuStim® System for the treatment of retinitis pigmentosa
2014     NIHR Health Services and Delivery Research programme Informing the development of NICE (National Institute for Health and Care Excellence) quality standards through secondary analysis of qualitative narrative interviews on patients' experiences
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Simeprevir (Galexos — Janssen Inc.) indication: chronic hepatitis C genotype 1 infection
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ruxolitinib - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     NIHR Health Technology Assessment programme Folate Augmentation of Treatment – Evaluation for Depression (FolATED): randomised trial and economic evaluation
2014     Penn Medicine Center for Evidence-based Practice (CEP) Automated hand hygiene monitoring systems
2014     NIHR Horizon Scanning Centre (NIHR HSC) LipiView® and LipiFlow® for dry eye management
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aclidinium bromide (Tudorza Genuair — Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014     Norwegian Knowledge Centre for the Health Services (NOKC) [Effects of using social media in health awareness campaigns to promote healthy lifestyle habits]
2014     NIHR Health Technology Assessment programme Interventions for central serous retinopathy: a network meta-analysis
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Implantable carotid sinus baroreflex device for the treatment of drug-resistant hypertension
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Perampanel - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014     Penn Medicine Center for Evidence-based Practice (CEP) Opioid-induced sedation scales
2014     NIHR Horizon Scanning Centre (NIHR HSC) Eluxadoline (Mu Delta) for irritable bowel syndrome (diarrhoea-predominant) – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox — Allergan Inc.) indication: chronic migraine
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Online programs for weight loss
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Siltuximab - Assessment according to § 35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) The Debrisoft monofilament debridement pad for use in acute or chronic wounds. NICE medical technologies guidance 17
2014     NIHR Horizon Scanning Centre (NIHR HSC) Prucalopride (Resolor) for adult males with chronic constipation – third line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro — UCB Canada Inc.) indication: idiopathic parkinson disease (early and advanced)
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elosulfase alfa - Assessment according to § 35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids]
2014     Health Quality Ontario (HQO) Robotic-assisted minimally invasive prostatectomy: OHTAC recommendation
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for Crohn's disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra — Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) HPV OncoTect™ E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening